AMN Healthcare (NYSE: AMN) CLO details RSU vesting and 19,641 grant

Rhea-AI Filing Summary

AMN Healthcare Services Inc. Chief Legal Officer Whitney M. Laughlin reported equity award activity dated January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were converted into shares of AMN common stock, with portions of the resulting shares withheld to cover taxes at a price of $19.55 per share.

The filing shows RSU conversions of 202, 749 and 3,537 units into common stock, paired with tax withholdings of 60, 223 and 1,049 shares, respectively. Following these transactions, Laughlin held 23,652 shares of AMN common stock directly.

On the same date, Laughlin received a new grant of 19,641 RSUs under the AMN Healthcare 2025 Equity Plan, each unit representing a right to receive one share of common stock. After this grant, Laughlin beneficially owned 39,282 RSUs, which vest in three annual tranches starting from their respective grant dates.

Insider Trade Summary

4,488 shares exercised/converted

Mixed 10 txns

Insider Laughlin Whitney M

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	202	$0.00	--
Exercise	Restricted Stock Units	749	$0.00	--
Exercise	Restricted Stock Units	3,537	$0.00	--
Grant/Award	Restricted Stock Units	19,641	$0.00	--
Exercise	Common Stock	202	$0.00	--
Tax Withholding	Common Stock	60	$19.55	$1K
Exercise	Common Stock	749	$0.00	--
Tax Withholding	Common Stock	223	$19.55	$4K
Exercise	Common Stock	3,537	$0.00	--
Tax Withholding	Common Stock	1,049	$19.55	$21K

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 20,698 shares (Direct)

Footnotes (1)

1. Common stock acquired on the vesting of Restricted Stock Units. Number of shares withheld for tax purposes. The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. Restricted Stock Units do not have an expiration date. The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Laughlin Whitney M

(Last) (First) (Middle)

2999 OLYMPUS BOULEVARD, SUITE 500

(Street)

DALLAS TX 75019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		M(1)		202	A	$0	20,698	D
Common Stock	01/15/2026		F(2)		60	D	$19.55	20,638	D
Common Stock	01/15/2026		M(1)		749	A	$0	21,387	D
Common Stock	01/15/2026		F(2)		223	D	$19.55	21,164	D
Common Stock	01/15/2026		M(1)		3,537	A	$0	24,701	D
Common Stock	01/15/2026		F(2)		1,049	D	$19.55	23,652	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	01/15/2026		M			202	(4)	(5)	Common Stock	202	$0	0	D
Restricted Stock Units	(3)	01/15/2026		M			749	(6)	(5)	Common Stock	749	$0	772	D
Restricted Stock Units	(3)	01/15/2026		M			3,537	(7)	(5)	Common Stock	3,537	$0	7,182	D
Restricted Stock Units	(8)	01/15/2026		A		19,641		(9)	(5)	Common Stock	19,641	$0	39,282	D

Explanation of Responses:

1. Common stock acquired on the vesting of Restricted Stock Units.

2. Number of shares withheld for tax purposes.

3. The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

4. The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

5. Restricted Stock Units do not have an expiration date.

6. The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

7. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

8. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

9. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

Remarks:

	/s/ Whitney M. Laughlin	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AMN (AMN) report for Whitney M. Laughlin on January 15, 2026?

The filing reports that Chief Legal Officer Whitney M. Laughlin had multiple blocks of Restricted Stock Units (RSUs) vest and convert into AMN common stock, with a portion of the resulting shares withheld for taxes, and also received a new RSU grant on January 15, 2026.

How many AMN common shares does Whitney M. Laughlin hold after these Form 4 transactions?

After the reported RSU vestings, conversions and tax withholdings, Whitney M. Laughlin beneficially owned 23,652 shares of AMN common stock directly.

What new RSU award did AMN grant to its Chief Legal Officer on January 15, 2026?

On January 15, 2026, AMN granted 19,641 Restricted Stock Units to Whitney M. Laughlin under the AMN Healthcare 2025 Equity Plan, with each RSU representing a contingent right to receive one share of AMN common stock.

What is the total RSU balance for Whitney M. Laughlin after the new AMN grant?

Following the new grant of 19,641 RSUs, the Form 4 shows that Laughlin beneficially owned 39,282 RSUs in total, all held directly.

How were taxes handled on Whitney M. Laughlin’s AMN RSU vestings?

For each RSU vesting, a portion of the acquired common shares was withheld for tax purposes, with the withholding transactions priced at $19.55 per share, as noted in the filing.

What are the vesting terms of the AMN RSUs reported for Whitney M. Laughlin?

The footnotes state that the RSUs granted on January 15, 2023, 2024, 2025 and 2026 vest in three tranches on each of the first, second and third anniversaries of the relevant grant date, subject to the grantee’s credited service.